NATCO Pharma Announces Closure of ₹12,794 Million Rights Issue
Natco Pharma Ltd · Rights Issue · 22 Oct 2026, 6:55 pm
NATCO Pharma Announces Closure of ₹12,794 Million Rights Issue NATCO Pharma Limited confirmed the closure of its Rights Issue on 22nd Oct'26, which originally opened on 12th Oct'26. The issue comprised equity shares of face value ₹2 each offered at a cash price of ₹750 per share, raising an aggregate amount of up to ₹12,794 million. The issue terms were previously approved by the Board of Directors on 25th Sep'26 in compliance with SEBI ICDR Regulations and the Companies Act.
Original exchange filing (PDF)
More announcements from Natco Pharma Ltd
- Intimation of Investor Meet · 17 Nov 2026
- Audio link of Earnings Conference Call Q2FY27 · 14 Nov 2026
- Q2 FY27 Earnings Presentation · 13 Nov 2026
- Un audited Financial Results for the quarter and half year ended 30th September, 2026 · 13 Nov 2026
- 19th November, 2026 is the Record Date for the payment of 2nd Interim Dividend for FY 2026-27 · 13 Nov 2026
- Natco Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026 and declaration of 2nd Interim Dividend for FY 2026-27 · 13 Nov 2026
- Outcome of Board Meeting · 13 Nov 2026
- Intimation of schedule of Concall · 13 Nov 2026
